Decision-Making and Process

In a recent internal planning session for Corval, our new cloud-based commercialization planning platform, we debated whether the term “Freedom to Lead” would resonate with our audience of early- to mid-stage biopharma companies. 

Among all the days of the calendar, February 29th is the rarest of them all. That's why, back in 2008, on the 25th anniversary of the Orphan Drug ACT, EURORDIS (The European Organization for Rare Disorders) designated the last day of February as "Rare Disease Day."

Maybe you noticed – 2020 was a crazy year. Like meeting the Pope or becoming a parent for the first time, the phrase "once in a lifetime" keeps popping up in conversation as a way to describe what we are all living through. Hopefully, in the case of last year, the description is on target and won't happen again, in our lifetime.

Over the past several years, The NemetzGroup has worked with numerous clients to develop key aspects of their S-1 filings — coordinating with bankers, attorneys, internal staff, and many more attorneys, all with the goal of helping these companies achieve successful public offerings.

We are fortunate to work with clients of all sizes, whose products are at various stages of their life cycle. But the angst around how to achieve a successful launch is generally the same, no matter the company.

Workshops, whether in the form of a half-day strategy session, a company-wide offsite or some other configuration, have one thing in common: They represent an opportunity for a group of people to come together in real time — to establish connections, share information, generate solutions, and achieve clear objectives. When done well, they are more than just meetings — they are highly structured, interactive, rewarding, and dare I say, fun!

In just one month, life for all of us has changed dramatically. This week, we learned that the new normal would extend at least through April, probably longer.

Many years ago, when we first started working with emerging life sciences companies to provide a roadmap for the commercialization of their technologies, we began with a list of essential activities and the corresponding budget that would be required.